Advertisement

Short-term Follow-up Study of Thyroid Function in Polytransfused Thalassemic Patients

  • S. Andò
  • M. Maggiolini
  • G. De Luca
  • M. Bria
  • D. Sisci
  • M. Lanzino
  • S. Aquila
  • V. Pezzi
  • A. Giorno
  • M. Caracciolo
  • M. G. Bisconte
  • E. Corcioni
  • C. Brancati

Abstract

Among the endocrine abnormalities involving thalassemic patients, the incidence of thyroid disorders shows a large variability [1–8]. We attempted to investigate the evolutive trend of thyroid function with elapsing of time and its relationship with chelation therapy. We have carried out a follow0up study of thyroid function in 45 polytransfused thalassemic patients, investigated in 1988 and again in 1992.

Keywords

Thyroid Function Serum Ferritin Iron Overload Ferritin Level Subclinical Hypothyroidism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Landau H, Spitz IM, Cividalli G, Rachmilewitz EA (1978) Gonadotrophin, thyrotrophin, and prolactin reserve in p-thalassaemia. Clin Endocrinol(oxf), 9: 163–173CrossRefGoogle Scholar
  2. 2.
    Madeddu G, Dore A, Marongiu A, Langer Costanzi M (1978) Growth retardation, skeletal maturation and thyroid function in children with homozygous p-thalassemia. Clin Endocrinol (oxf), 8: 359–365CrossRefGoogle Scholar
  3. 3.
    Costin G, Kogut MD, Hyman C, Ortega JA (1979) Endocrine abnormalities in thalassemia major. AmJ Dis Child 133: 497–502Google Scholar
  4. 4.
    De Sanctis V, Pintor C, Aliquo S, Anastasi S, Borgna-Pignatti C, Brancati C et al. (1990) Preliminary data on prevalence of endocrine complications in patients with p–thalassemia major: an Italian multicenter study. In: ( Pintor C, Corda R, De Sanctis V ) (eds) Porto Cervo, Sardinia Workshop on Endocrine Problems in Thalassemia, Oct 11Google Scholar
  5. 5.
    De Sanctis V, Pintor C, Ando S, Aliquo MC, Anastasi S, Brancati C et al. (1992) Prevalence of endocrine complications in patients with p-thalassemia major: an Italian multicenter study. International Mediterranean Conference on Endocrine Disorder in Thalassemia, May 7-9, CosenzaGoogle Scholar
  6. 6.
    Livadas D, Sofroniadou K, Souvatzoglou A, Boukis M, Siafaka L, Koutras D (1984) Pituitary and thyroid insufficiency in thalassemic haemosiderosis. Clin Endocrinol(oxf), 20: 435–443CrossRefGoogle Scholar
  7. 7.
    Phenekos C, Karamerou A, Pipis P, Constantoulakis M, Lasaridis J, Detsi S, Politou K (1984) Thyroid function in patients with homozygous p-thalassemia. Clin Endocrinol(oxf) 20: 445–450CrossRefGoogle Scholar
  8. 8.
    Bisbocci D. Sperone D, Camaschella C, Bertero T, Livorno P, Degani G, D’Alberto M (1987) Hyperresponsiveness of plasma TSH to TRH and thyroid antibodies in postpubertal clinically euthyroid patients with thalassemia major. Ital 3: 47–52Google Scholar
  9. 9.
    Modell B, Berdoukas V (1984) Iron overload — desferoxamine. In: The clinical approach to thalassemia. Grune and Stratton, Orlando, pp 198–240Google Scholar
  10. 10.
    Bartalena L, Bogazzi F, Pinchera A (1991) Thyroid function tests and diagnostic protocols for investigation of thyroid dysfunction. Ann 1st Super Sanita 27 (3): 531–540Google Scholar
  11. 11.
    Bogner U, Arntz HR, Peters H, Schleusener H (1993) Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified. Acta Endocrinol (Copenh) 128: 202–206PubMedGoogle Scholar
  12. 12.
    Chanoine JP, Toppet V, Lagasse R, Spehl M, Delange F (1991) Determination of thyroid volume by ultrasound from the neonatal period to adolescence. Eur Pediatr 150: 395–399CrossRefGoogle Scholar
  13. 13.
    Weintraub LR, Goral A, Grasso J, Franzblau C, Sullivan A, Sullivan S (1988) Collagen biosynthesis in iron overload. Ann NY Acad 526: 179–184CrossRefGoogle Scholar
  14. 14.
    Worwood M, Cragg SJ, Jacobs A, McLaren C, Ricketts C, Economidou J (1980) Binding of serum ferritin to concanavalin A: patients with homozygous p-thalassemia and transfusional iron overload. Br Haematol 46: 409–416CrossRefGoogle Scholar
  15. 15.
    Cazzola M, Borgna-Pignatti C, Da Stefano P, Bergamashi G, Bongo IG, Dezza L, Avato F (1983) Internal distribution of excess iron and sources of serum ferritin in patients with thalassemia. Scand Haematol 30: 289–296CrossRefGoogle Scholar
  16. 16.
    Cohen A, Martin M, Schwartz E (1981) Response to long-term desferoxamine therapy in thalassemia. J Pediatr 99: 689–694PubMedCrossRefGoogle Scholar
  17. 17.
    Long RG (1980) Endocrine aspects of liver disease. Br Med J 1: 225–228CrossRefGoogle Scholar
  18. 18.
    Chopa IJ (1987) Alterations in thyroid physiology in liver disease. Serono Symp Publ 43: 157–164Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • S. Andò
  • M. Maggiolini
  • G. De Luca
  • M. Bria
  • D. Sisci
  • M. Lanzino
  • S. Aquila
  • V. Pezzi
  • A. Giorno
  • M. Caracciolo
  • M. G. Bisconte
  • E. Corcioni
  • C. Brancati

There are no affiliations available

Personalised recommendations